{
  "docId": "019dd923-5e88-73ef-bd5a-9cdc5d048fe2",
  "docSlug": "03e126adc7ca1480",
  "documentTitle": "20250114 bayer handout jpm 2025",
  "authorId": "JPMorgan",
  "authorName": "Bayer",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 9,
  "pageCount": 18,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "market_landscape",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "Includes market share trend charts for Japan and Switzerland.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "line_chart",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-9cdc5d048fe2/9",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.72,
        "w": 0.26,
        "x": 0.71,
        "y": 0.21
      },
      "kind": "callout",
      "text": "Perspectives 2025 and beyond: Expect continued growth for anti-VEGF market ~3-4% CAGR 2024 - 2033; Execute on continued 8mg launches and PFS roll-out; Expect first data from RWE study SPECTRUM in H1 2025",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed516a40-544b-4c58-8527-ff6e71b4acf7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Expect continued growth for anti-VEGF market ~3-4% CAGR 2024 - 2033",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-2301-748f-910f-58b44311b7bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.6,
        "x": 0.08,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Strong market share uptake observed in first-wave countries",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc420564-72c4-48e7-9098-fd2395670bb6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.08,
        "y": 0.42
      },
      "kind": "list",
      "text": "Unprecedented clinical profile consistently confirmed across Phase III studies; First drug with approved treatment interval of up to 5 months in nAMD and DME; Pre-filled syringe availabe (PFS) since September 2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4347619-fb60-4780-b015-959b7042c0d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Market Share: 66.6%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-2301-748f-910f-5fd04bcce888",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.08,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "EYLEA is the #1 anti-VEGF treatment since 2016",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7127cbf2-5c92-4ab4-baef-867dce7d4038",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.08,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source: MIDAS LC EUR Oct.24",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99a0bd53-d615-4071-83b8-fefd873b5219",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.08,
        "y": 0.05
      },
      "kind": "title",
      "text": "Eylea: Leader in Retinal Market and Well-Positioned to Sustain Market Position",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f23eeb3-806e-4976-84ad-c47fc9f4b964",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 9,
      "beatId": "f381b448-fcf0-4030-b26e-c9fd2c74d1c9",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The slides showcase the company's market-leading positions and innovation",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "6ade2762-544e-41aa-adcf-f0724dca9dce",
      "evidence": "The slides highlight the company's 'why', 'what', and 'how'",
      "position": 1,
      "objective": "Why is Bayer's strategic agenda important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}